Quarterly report [Sections 13 or 15(d)]

Royalty and Commercial Payment Purchase Agreements - Summary of Royalty Receivable Activities (Details)

v3.25.3
Royalty and Commercial Payment Purchase Agreements - Summary of Royalty Receivable Activities (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Royalty and Commercial Payment Receivable Activities Under the Cost Recovery Method        
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method     $ 56,349  
Acquisition of Royalty and Commercial Payment Receivables, Cost Recovery Method     4,395  
Receipt of Royalty and Commercial Payments, Cost Recovery Method     (1,980)  
Balance at End of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method $ 58,764   58,764  
Contingent consideration under RPAs, AAAs, and CPPAs        
Payment of contingent consideration related to Kinnate IP asset     (550)  
Royalty and Commercial Payment Receivable Activities Under the EIR Method        
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, EIR Method     19,733  
Income from Purchased Receivables Under the EIR Method 6,962 $ 5,423 19,039 $ 9,985
Receipt of Royalty and Commercial Payments, EIR Method     (23,825)  
Payment of Sales-Based Milestone     3,000  
Balance at End of Period, Royalty and Commercial Payment Receivables, EIR Method 17,947   17,947  
Income        
Income from purchased receivables under the EIR method 6,962 5,423 19,039 9,985
Income from purchased receivables under the cost recovery method 1,857 1,040 9,125 1,910
Twist        
Royalty and Commercial Payment Receivable Activities Under the Cost Recovery Method        
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method     15,000  
Balance at End of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method 15,000   15,000  
Dare | XACIATO        
Royalty and Commercial Payment Receivable Activities Under the Cost Recovery Method        
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method     21,999  
Receipt of Royalty and Commercial Payments, Cost Recovery Method     (4)  
Balance at End of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method 21,995   21,995  
LadRx | MIPLYFFA        
Royalty and Commercial Payment Receivable Activities Under the Cost Recovery Method        
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method     4,850  
Receipt of Royalty and Commercial Payments, Cost Recovery Method     (1,976)  
Balance at End of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method 2,874   2,874  
Palobiofarma        
Royalty and Commercial Payment Receivable Activities Under the Cost Recovery Method        
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method     10,000  
Balance at End of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method 10,000   10,000  
Kuros        
Royalty and Commercial Payment Receivable Activities Under the Cost Recovery Method        
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method     4,500  
Balance at End of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method 4,500   4,500  
Castle Creek Biosciences, Inc        
Royalty and Commercial Payment Receivable Activities Under the Cost Recovery Method        
Acquisition of Royalty and Commercial Payment Receivables, Cost Recovery Method     4,395  
Balance at End of Period, Royalty and Commercial Payment Receivables, Cost Recovery Method 4,395   4,395  
Affitech | VABYSMO        
Royalty and Commercial Payment Receivable Activities Under the EIR Method        
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, EIR Method     13,105  
Income from Purchased Receivables Under the EIR Method 6,723 5,423 18,298 9,985
Receipt of Royalty and Commercial Payments, EIR Method     (22,507)  
Payment of Sales-Based Milestone     3,000  
Balance at End of Period, Royalty and Commercial Payment Receivables, EIR Method 11,896   11,896  
Income        
Income from purchased receivables under the EIR method 6,723 5,423 18,298 9,985
Aptevo | IXINITY        
Royalty and Commercial Payment Receivable Activities Under the EIR Method        
Balance at Beginning of Period, Royalty and Commercial Payment Receivables, EIR Method     6,628  
Income from Purchased Receivables Under the EIR Method 239   741  
Receipt of Royalty and Commercial Payments, EIR Method     (1,318)  
Balance at End of Period, Royalty and Commercial Payment Receivables, EIR Method 6,051   6,051  
Income        
Income from purchased receivables under the EIR method 239   741  
Viracta | OJEMDA        
Income        
Income from purchased receivables under the cost recovery method $ 1,857 $ 1,040 9,097 $ 1,910
Talphera        
Income        
Income from purchased receivables under the cost recovery method     $ 28